Netherlands· NL-dfd24c2a893b
Natriumcromoglicaat Medcor, granulaat in sachets 200 mg
A cromoglicic acid product containing dinatriumcromoglicaat, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 6 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Cromoglicic acid is registered in 6 of 19 countries.
Countries holding a registration under ATC A07EB01 (cromoglicic acid), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 3 of them publish a price we can compare per daily dose
Cromoglicic acid · ATC A07EB01
6 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Japan
- Netherlands
- Norwayprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DINATRIUMCROMOGLICAAT
- Manufacturer
- Medcor Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- A07EB01
- ATC class
- Cromoglicic acid
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id127196//10228
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
130 interactions on record for cromoglicic acid.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cromoglicic acid · interactions on record
130 records
- 5 moderate
- 125 info
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cromoglicic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayPentatopPädia
- United KingdomAllercrom 2% eye dropsViatris UK Healthcare Ltd
- FinlandBlacilOrion Corporation Orion Pharma
- GermanyAllergovalKoehler Pharma Gmbh
- United Statescromolyn sodiumMylan Pharmaceuticals Inc.
- FranceALAIRGIX RHINITE ALLERGIQUE CROMOGLICATE DE SODIUM 2 %, solution pour pulvérisation nasaleCOOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- BelgiumAlleophta Unidosis 20 mg/mlOpella Healthcare Belgium
- SwedenAllgil 20 mg/ml Ögondroppar, lösningEvolan Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Allergo-Comod, Allergocrom
- Belgium · Allergo-Comod, Cromabak
- Bulgaria · Lecrolyn Sine
- Cyprus · Cromodal, Vividrin
- Czechia · Allergo-Comod, Allergocrom
- Germany · Allergoval, Cromo
- Denmark · Lecrolyn Sine, Lomudal
- Estonia · Lecrolyn, Lecrolyn Sine
- Spain · Gastrofrenal
- Finland · Lecrolyn, Lecrolyn Sine
- France · Alairgix Rhinite Allergique, Allergocomod
- United Kingdom (Northern Ireland) · Alleopti Allergy, Alleopti Hayfever
- Greece · Allergotin, Chromoprol
- Hungary · Lecrolyn, Taleum
- Ireland · Opticrom, Opticrom Allergy
- Iceland · Lecrolyn Sine, Lomudal
- Italy · Brunicrom, Lecrosine
- Lithuania · Lecrolyn, Lecrolyn Sine
- Luxembourg · Allergo-Comod, Cromabak
- Latvia · Lecrolyn Sine
- Malta · Allergo-Comod, Allergotin
- Norway · Lecrolyn Sine, Lomudal
- Poland · Allergo-Comod, Allergocrom
- Portugal · Allergocrom, Cromabak
- Romania · Alergorom, Lecrolyn
- Sweden · Allgil, Lecrolyn
- Slovakia · Allergocrom, Lecrolyn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/10fb0808-90d9-4a8f-a5bd-2e0753e3d640 GET /v1/drugs/10fb0808-90d9-4a8f-a5bd-2e0753e3d640?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulaat",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h10228_smpc.pdf",
"strength": null,
"atc_label": "Cromoglicic Acid",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127196",
"excipients": [
"SACCHAROSE"
],
"substances": [
"DINATRIUMCROMOGLICAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127196.pdf",
"authorised_at": "2024/04/15",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "127196//10228",
"additional_monitoring": "N"
}See everything about cromoglicic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.